These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27190374)

  • 81. Lanthanum carbonate versus standard therapy for the treatment of hyperphosphatemia: safety and efficacy in chronic maintenance hemodialysis patients.
    Finn WF;
    Clin Nephrol; 2006 Mar; 65(3):191-202. PubMed ID: 16550750
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a randomized trial.
    Takahara Y; Matsuda Y; Takahashi S; Shigematsu T;
    Clin Nephrol; 2014 Sep; 82(3):181-90. PubMed ID: 25079863
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Solute kinetics with short-daily home hemodialysis using slow dialysate flow rate.
    Kohn OF; Coe FL; Ing TS
    Hemodial Int; 2010 Jan; 14(1):39-46. PubMed ID: 19758296
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Rebound kinetics of beta2-microglobulin after hemodialysis.
    Leypoldt JK; Cheung AK; Deeter RB
    Kidney Int; 1999 Oct; 56(4):1571-7. PubMed ID: 10504510
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Beta-2 microglobulin clearance in high-flux dialysis and convective dialysis modalities: a meta-analysis of published studies.
    Roumelioti ME; Trietley G; Nolin TD; Ng YH; Xu Z; Alaini A; Figueroa R; Unruh ML; Argyropoulos CP
    Nephrol Dial Transplant; 2018 Jun; 33(6):1025-1039. PubMed ID: 29186592
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Bioimpacts of dialyzer variety on phosphorus level in Iranian hemodialysis patients.
    Pezeshgi A; Moharrami B; Kolifarhood G; Sadeghi A; Asadi-Khiavi M
    J Renal Inj Prev; 2016; 5(2):94-7. PubMed ID: 27471742
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control.
    Botelho C; Rodrigues A; Oliveira JC; Cabrita A
    J Nephrol; 2013; 26(1):183-90. PubMed ID: 22460184
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of citrate acid concentrate (citrasate®) on heparin N requirements and hemodialysis adequacy: a multicenter, prospective noninferiority trial.
    Sands JJ; Kotanko P; Segal JH; Ho CH; Usvat L; Young A; Carter M; Sergeyeva O; Korth L; Maunsell E; Zhu Y; Krishnan M; Diaz-Buxo JA
    Blood Purif; 2012; 33(1-3):199-204. PubMed ID: 22269855
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy and Safety of Tenapanor in Patients with Hyperphosphatemia Receiving Maintenance Hemodialysis: A Randomized Phase 3 Trial.
    Block GA; Rosenbaum DP; Yan A; Chertow GM
    J Am Soc Nephrol; 2019 Apr; 30(4):641-652. PubMed ID: 30846557
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients.
    Coyne DW; Dagogo-Jack S; Klein S; Merabet E; Audrain J; Landt M
    Am J Kidney Dis; 1998 Dec; 32(6):1031-5. PubMed ID: 9856520
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison of urea clearance in low-efficiency low-flux vs. high-efficiency high-flux dialyzer membrane with reduced blood and dialysate flow: an in vitro analysis.
    Munshi R; Ahmad S
    Hemodial Int; 2014 Jan; 18(1):172-4. PubMed ID: 23714225
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Diffusive clearance of small and middle-sized molecules in combined dialyzer flow configurations.
    Eloot S; De Vos JY; Hombrouckx R; Verdonck P
    Int J Artif Organs; 2004 Mar; 27(3):205-13. PubMed ID: 15112886
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Sevelamer Versus Calcium-Based Binders for Treatment of Hyperphosphatemia in CKD: A Meta-Analysis of Randomized Controlled Trials.
    Patel L; Bernard LM; Elder GJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):232-44. PubMed ID: 26668024
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Safety and Efficacy of Tenapanor for Long-term Serum Phosphate Control in Maintenance Dialysis: A 52-Week Randomized Phase 3 Trial (PHREEDOM).
    Block GA; Bleyer AJ; Silva AL; Weiner DE; Lynn RI; Yang Y; Rosenbaum DP; Chertow GM
    Kidney360; 2021 Oct; 2(10):1600-1610. PubMed ID: 35372979
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study.
    Abe M; Masakane I; Wada A; Nakai S; Nitta K; Nakamoto H
    Clin Kidney J; 2022 Mar; 15(3):473-483. PubMed ID: 35211304
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Multidisciplinary Team versus a "Phosphate-Counting" App for Serum Phosphate Control: A Randomized Controlled Trial.
    Farfan-Ruiz AC; Czikk D; Leidecker J; Ramsay T; McCormick B; Wilson K; Zimmerman D
    Kidney360; 2021 Feb; 2(2):290-297. PubMed ID: 35373021
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Intradialytic Protein Ingestion and Exercise do Not Compromise Uremic Toxin Removal Throughout Hemodialysis.
    Hendriks FK; Kuijpers JHW; van Kranenburg JMX; Senden JMG; van der Sande FM; Kooman JP; Meex SJR; van Loon LJC
    J Ren Nutr; 2023 Mar; 33(2):376-385. PubMed ID: 35988911
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Postdialysis serum phosphate equilibrium in hemodialysis patients on a controlled diet and no binders.
    Stremke ER; Trevino L; Doshi S; Moorthi RN; Hill Gallant KM; Moe SM
    Hemodial Int; 2022 Apr; 26(2):255-263. PubMed ID: 34964250
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Poor Sleep Quality, Depression and Social Support Are Determinants of Serum Phosphate Level among Hemodialysis Patients in Malaysia.
    Ng ESY; Wong PY; Kamaruddin ATH; Lim CTS; Chan YM
    Int J Environ Res Public Health; 2020 Jul; 17(14):. PubMed ID: 32708766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.